LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
213,000
+13,100 (6.55%)
Mar 20, 2026, 3:30 PM KST
Market Cap7.75T +86.5%
Revenue (ttm)159.27B +57.0%
Net Income-25.13B
EPS-690.95
Shares Out36.41M
PE Ration/a
Forward PE180.77
Dividendn/a
Ex-Dividend Daten/a
Volume417,783
Average Volume471,684
Open201,500
Previous Close199,900
Day's Range196,800 - 218,000
52-Week Range89,500 - 225,000
Beta0.69
RSI60.76
Earnings DateMar 20, 2026

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements